Dazcapistat

(Synonyms: BLD-2660)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Dazcapistat (BLD-2660) is an orally active small-molecule inhibitor of calpain 1, 2, and 9 (calpain 1, 2, 9). Dazcapistat reduces the expression/production level of IL-6 in injured lung tissue and alleviates fibrosis. Dazcapistat exerts anti-fibrotic effects in various animal models of fibrosis in the skin, liver and lung. Dazcapistat can be used in research related to coronavirus disease 2019 (COVID-19) and idiopathic pulmonary fibrosis.

For research use only. We do not sell to patients.

  • Purity: 98.0%
  • CAS No.: 2221010-42-8
  • Formula: C21H18FN3O4
  • Molecular Weight:395.38
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Dazcapistat

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00